TORONTO GAIRDNER AWARDS ($100,000) : USA NIH Dr.Harvey J. ALTER co-discoverer of AUSTRALIA ANTIGEN

Lectured on Hepatitis C at the Sir Ka-shing LI GBM,KBE building of St.Michael's Teachimg hospital. Advised testing 48-68 age group. (Many used IV drugs between 1945 - 1965) 50% carriers not identified. 1-3% Worldwide infection. 60-70% show slow disease progress over 30 years 20- 30% develop cirrhosis in 15-40 years <5% develop cirrhosis in 5-10 years. Increased prevalence of Liver cancer due to Hep.C.